Erythropoietin and subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 112, Issue 3, 2010, Pages 699-700

  Grasso, Giovanni ^a   Sfacteria, Alessandra ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ANGIOGRAPHY; BRAIN ISCHEMIA; BRAIN VASOSPASM; DOSE RESPONSE; DRUG EFFECT; HUMAN; LETTER; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

ANIMALS; BRAIN ISCHEMIA; CLINICAL TRIALS, PHASE II AS TOPIC; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; NEUROPROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 77749279584     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.8.JNS09961     Document Type: Letter

References (8)

1. Brines M, Patel NS, Villa P, Brines C, Mennini T, De Paola M, et al: Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 105:10925-10930, 2008
2. Grasso G: Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 45:7-14, 2001
3. Grasso G: An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev 44:49-63, 2004
4. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, et al: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 99:5627-5631, 2002
5. Jackowski A, Crockard A, Burnstock G, Russell RR, Kristek F: The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat. J Cereb Blood Flow Metab 10:835-849, 1990
6. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242, 2004
7. Springborg JB, Ma X, Rochat P, Knudsen GM, Amtorp O, Paulson OB, et al: A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 135:823-829, 2002
8. Springborg JB, Møller C, Gideon P, Jørgensen OS, Juhler M, Olsen NV: Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial. Acta Neurochir (Wien) 149:1089-1101, 2007